trial

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

NCTId NCT00057135
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 150 (estimated)
Sponsored by US Department of Veterans Affairs
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
150 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
None
Start
2002-11
Primary completion
—
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Unit of use medication packagingMailed reminders to patient when medication refills are dueNote to Mental Health Provider when refill is overdueAligning all prescriptions to fall due on same date

Sponsors

US Department of Veterans AffairsLead Sponsor

Investigators

2
Marcia T. Valenstein, MD ABPrincipal Investigator
John Grabowski, MDPrincipal Investigator

Sites

5 total
San Diego, United StatesHines, United StatesEast Orange, United StatesAnn Arbor, United StatesDetroit, United States

Facts & assertions

3 sourced
Enrollment
150
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
Unit of use medication packaging
drug
Mailed reminders to patient when medication refills are due
drug
Note to Mental Health Provider when refill is overdue
drug
Aligning all prescriptions to fall due on same date
drug
lead_sponsor
US Department of Veterans Affairs
company
indication
Bipolar Disorder
indication
Treatment Refusal
indication
Schizoaffective Disorder
indication
investigator
Marcia T. Valenstein, MD AB
person
John Grabowski, MD
person